What's breaking now, across thousands of outlets.
After last year's successful $10 billion sale of Metsera, then launching an inflammatory disease biotech earlier this year, ARCH Venture Partners and Population Health Partners have teamed up again ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Infections caused by viruses, bacterium and parasites caused an estimated 2.3 million new cancer cases in 2024, with low- and middle-income countries bearing most of the burden.
Fresenius Kabi will sell biosimilars directly to employers. To accomplish that, the drugmaker is working with Eversana-owned Waltz Health, which runs a marketplace that helps employers shop for better…
During Donald Trump’s first presidency, American public opinion broadly shifted leftward. But a new study reveals this "liberal rebound" was accompanied by surging emotional hostility between…
President Donald Trump regularly defends his administration's record by contrasting it favorably with the Biden era, or other blaming the former president.
President Donald Trump regularly defends his administration's record by contrasting it favorably with the Biden era, or other blaming the former president.
A group of lawmakers spanning both parties and chambers is introducing legislation that would require insurance plans to cover genetic testing for patients with hereditary risk factors and expand…
